Product Images Marlissa

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Marlissa NDC 68462-388 by Glenmark Pharmaceuticals Inc., Usa, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

CTN

CTN

Marlissa is an oral contraceptive containing 615mg of levonorgestrel and 0.03mg of ethinyl estradiol per each of the 21 light orange or orange tablets. It comes in a package of three blisters, each containing 28 tablets. The usual dosage is one tablet per day for 21 days, followed by a 7-day break. Each blister pack has a unique NDC number. The storage temperature must be controlled, and customers can contact a phone number for more information.*

Figure 2

Figure 2

This appears to be a list of studies conducted to compare the use of combined oral contraceptives (COC) versus never using them, and current users versus never-users. The studies include the NICHD Women's Care Study, French E3N Cohort Study, Shanghai Women's Health Study, Nurses' Health Study II, Danish Sex Hormone Register Study, and Oxford Family Planning Study. The results are presented as effect estimates (OR, RR, HR) and confidence intervals for the various studies. There is also a chart with numbers ranging from -1.5 to 2.0, but without additional context or labels, it's unclear what it represents.*

Figure1

Figure1

This is a statistics table regarding blood clotting in women based on their pregnancy status and contraceptive use. The table shows the number of women out of 10,000 who experienced blood clots in different categories, including non-pregnant women, women who do not use combined oral contraceptives, women who use combined oral contraceptives, women in early pregnancy, and women in postpartum (up to 12 weeks after childbirth). The pregnancy data is based on actual durations of pregnancy in reference studies.*

FigureA

FigureA

Logo

Logo

This appears to be a company name, "Glenmark". It is likely a pharmaceutical company based on the context of the text.*

StructureEE

StructureEE

StructureLevonorgestrel

StructureLevonorgestrel

Glenmark logo - image 05

Glenmark logo - image 05

This appears to be a table or chart with various methods of birth control and their efficacy rates displayed in terms of pregnancies per 100 women. The methods include injections, intrauterine devices, sterilization, birth control pills, the skin patch, the vaginal ring, the diaphragm, spermicide, and withdrawal. There are also categories for pregnancies per 100 women over 55 years old and for fewer pregnancies overall. The text does not provide enough context or detail to give a complete description.*

image 08

image 08

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.